William Sullivan, MD | |
5100 E Highway 90, Suite B, Sierra Vista, AZ 85635-2443 | |
(520) 417-9729 | |
(520) 417-9733 |
Full Name | William Sullivan |
---|---|
Gender | Male |
Speciality | Psychiatry |
Experience | 32 Years |
Location | 5100 E Highway 90, Sierra Vista, Arizona |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1154483477 | NPI | - | NPPES |
192774 | Other | AZ | AHCCCS |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
2084P0800X | Psychiatry & Neurology - Psychiatry | MD 22176 (Arizona) | Primary |
Entity Name | Sullivan Md Pllc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1851531933 PECOS PAC ID: 0042377269 Enrollment ID: O20090316000131 |
News Archive
SANE Australia has revealed data that shows that nearly 90% of patients with mental illness also suffer from chronic ailments like diabetes, heart disease etc.
St. Jude Children's Research Hospital scientists have identified a signature immune response that might help doctors identify which newly diagnosed influenza patients are most likely to develop severe symptoms and suffer poor outcomes. The findings also help explain why infants and toddlers are at elevated risk for flu complications. The research appears in the upcoming issue of the American Journal of Respiratory and Critical Care Medicine.
A protein known to repress gene transcription at the molecular level in a variety of processes also blocks embryonic neural stem cells from differentiating into neurons, according to a study by University of California, San Diego and Howard Hughes Medical Institute (HHMI) researchers published online October 10 in Nature.
CTI BioPharma Corp. announced today that it has completed recruitment in the PERSIST-1 pivotal Phase 3 clinical trial of pacritinib, a novel oral JAK2/FLT3 inhibitor that is being evaluated for the treatment of myelofibrosis.
› Verified 9 days ago
Mailing Address | Practice Location Address |
---|---|
William Sullivan, MD 5100 E Highway 90, Suite B, Sierra Vista, AZ 85635-2443 Ph: (520) 417-9729 | William Sullivan, MD 5100 E Highway 90, Suite B, Sierra Vista, AZ 85635-2443 Ph: (520) 417-9729 |
News Archive
SANE Australia has revealed data that shows that nearly 90% of patients with mental illness also suffer from chronic ailments like diabetes, heart disease etc.
St. Jude Children's Research Hospital scientists have identified a signature immune response that might help doctors identify which newly diagnosed influenza patients are most likely to develop severe symptoms and suffer poor outcomes. The findings also help explain why infants and toddlers are at elevated risk for flu complications. The research appears in the upcoming issue of the American Journal of Respiratory and Critical Care Medicine.
A protein known to repress gene transcription at the molecular level in a variety of processes also blocks embryonic neural stem cells from differentiating into neurons, according to a study by University of California, San Diego and Howard Hughes Medical Institute (HHMI) researchers published online October 10 in Nature.
CTI BioPharma Corp. announced today that it has completed recruitment in the PERSIST-1 pivotal Phase 3 clinical trial of pacritinib, a novel oral JAK2/FLT3 inhibitor that is being evaluated for the treatment of myelofibrosis.
› Verified 9 days ago
Dr. Frederique P. Delhaye, M.D. Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 5750 E Highway 90 Ste 200, Sierra Vista, AZ 85635 Phone: 520-263-3500 | |
Dr. Dorlyne Michelle Brchan, M.D. Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 5750 E Highway 90 Ste 200, Sierra Vista, AZ 85635 Phone: 520-263-3670 Fax: 202-633-6715 | |
Dr. James Phillip Reed, D.O. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 4151 La Linda Way, Suite 102, Sierra Vista, AZ 85635 Phone: 520-515-9610 Fax: 520-515-0031 |